Diseases
Companies
Products
Productz
Mechanisms of Action
Sites
Sansulin Log-G
(insulin glargine biosimilar) /
Sanbe
Welcome,
Profile
Billing
Logout
Diseases
Trials
Trials
News
|
|||||||||
Lantus
(insulin glargine) /
Sanofi
,
Sansulin Log-G
(insulin glargine biosimilar) /
Sanbe
New P2 trial:
The Efficacy, Safety, and Immunogenicity Study Comparing an Insulin Glargine Biosimilar Sansulin Log-G to Lantus
(clinicaltrials.gov) - Oct 18, 2020
P2
, N=120, Not yet recruiting,
Sponsor: Indonesia University